Storms start to move out of Minnesota, continue for western Wisconsin

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

Bruce Kramer believed that researchers need to rethink the way they test new drugs on ALS patients like him. 

He argued that the double-blind testing model doesn't work for a devastating fatal illness like ALS. 

In this episode of Living While Dying, we also hear from a bio-ethicist about the decision to deny some patients access to an experimental drug.

Subscribe to the podcast

Bruce Kramer believed that researchers need to rethink the way they test new drugs on ALS patients like him.

Bruce Kramer believed that researchers need to rethink the way they test new drugs on ALS patients like him. He argued that the double-blind testing model doesn't work for a devastating fatal illness like ALS. In this episode of Living While Dying, we also hear from a bio-ethicist about the decision to deny some patients access to an experimental drug.

'Living While Dying' episode 14: Drug trial ethics

Go Deeper.

Like this?